Xavier Adhoute

机构：Hôpital Saint Joseph · ORCID：0000-0001-5977-800X

发表论文 99 篇 · 总被引 2495 次 · h-index 23

代表论文

• The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active (2025 · Nature Communications · 被引 16)
• Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective (2023 · Targeted Oncology · 被引 14)
• Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching (2022 · World Journal of Gastrointestinal Oncology · 被引 13)
• Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆ (2024 · JHEP Reports · 被引 11)
• Radiomics, a Promising New Discipline: Example of Hepatocellular Carcinoma (2023 · Diagnostics · 被引 11)
• Surgical treatment of tertiary hyperparathyroidism: does one fit for all? (2023 · Frontiers in Endocrinology · 被引 6)